Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.21.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Revenues    
Total revenues $ 11,313 $ 3,385
Cost of sales    
Total cost of sales 11,900 6,204
Gross margin (587) (2,819)
Operating expenses    
Research and development 10,858 12,340
Sales and marketing 5,449 4,494
General and administrative 13,846 2,625
Total operating expenses 30,153 19,459
Loss from operations (30,740) (22,278)
Change in fair value of warrant liability (56,576)  
Interest expense (73) (104)
Interest and other income, net 361 578
Loss before income taxes (87,028) (21,804)
Income tax benefit 27,920 0
Net loss $ (59,108) $ (21,804)
Net loss per share-basic and diluted $ (0.25) $ (0.14)
Products    
Revenues    
Total revenues $ 10,311 $ 2,694
Cost of sales    
Total cost of sales 10,487 5,041
Services    
Revenues    
Total revenues 1,002 691
Cost of sales    
Total cost of sales $ 1,413 $ 1,163